J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e200-e204. doi: 10.1016/j.japh.2020.07.004. Epub 2020 Aug 13.
To develop and assess the reliability of a tool that measures community pharmacist potential to influence prescriber quality measure performance.
Multidisciplinary, health care subject matter experts were convened to determine the criteria that evaluate the community pharmacist's ability to influence quality measure performance and a scoring mechanism. The draft tool was reviewed by investigators and subject matter experts in various health care professional settings to assess face validity and make refinements. Interrater reliability was assessed by 2 independent reviewers using a random 20% sample of the 2017 Merit-based Incentive Payment System (MIPS) measure set. Absolute agreement and kappa statistics were calculated, and the tool was iteratively refined based on the results. The tool was then applied to the full 2017 MIPS measure set by 2 reviewers, and interrater reliability was assessed.
The quality measure impact tool-community pharmacy (QMIT-CP) comprised 5 criteria, which assessed the quality measures of the community pharmacist's influence potential. The criteria evaluated whether the quality measures: (1) addressed the use of medications or immunizations; (2) included a condition treatable by medications; (3) treated patients in an outpatient setting; (4) included outcomes; and (5) evaluated whether relevant measure data were available to community pharmacists. All criteria used a dichotomous scale, and the summed scores were used to categorize the pharmacist's influence potential as "high" (4-5), "moderate" (2-3), or "low" (0-1). Kappa statistics ranged from "substantial agreement" (≥0.6) to "almost perfect agreement" (≥0.8) for individual QMIT-CP criteria and overall pharmacist influence potential categorization.
The QMIT-CP is a reliable tool to identify quality measures and assess the high, moderate, or low influence potential that community pharmacists may have. The QMIT-CP can be used to support innovative team-based care and enhance value-based contracting by identifying relevant measures that community pharmacists have the potential to influence.
开发并评估一种工具的可靠性,该工具用于衡量社区药剂师影响处方质量措施表现的潜力。
召集多学科、医疗保健主题专家,以确定评估社区药剂师影响质量措施表现能力的标准和评分机制。研究人员和各种医疗保健专业环境中的主题专家对工具草案进行了审查,以评估表面效度并进行改进。两名独立评审员使用 2017 年基于质量的激励支付系统(MIPS)措施集的随机 20%样本评估了评分者间信度。计算了绝对一致性和 Kappa 统计量,并根据结果对工具进行了迭代改进。然后,两名评审员应用该工具对整个 2017 年 MIPS 措施集进行评估,并评估了评分者间信度。
质量措施影响工具-社区药房(QMIT-CP)由 5 个标准组成,评估了社区药剂师影响潜力的质量措施。这些标准评估了质量措施是否:(1)针对药物或免疫接种的使用;(2)包括可通过药物治疗的病症;(3)治疗门诊患者;(4)包括结果;(5)评估社区药剂师是否可获得相关措施数据。所有标准均采用二分制,根据总分将药剂师的影响潜力分为“高”(4-5)、“中”(2-3)或“低”(0-1)。对于个别 QMIT-CP 标准和整体药剂师影响潜力分类,Kappa 统计量从“高度一致”(≥0.6)到“几乎完美一致”(≥0.8)不等。
QMIT-CP 是一种可靠的工具,可用于识别质量措施,并评估社区药剂师可能具有的高、中、低影响潜力。QMIT-CP 可用于通过确定社区药剂师具有潜在影响力的相关措施,支持创新的团队式护理和增强基于价值的合同。